Status:

COMPLETED

Serratus Anterior Plane Block Versus Standard of Care After Totally Endoscopic Aortic Valve Replacement

Lead Sponsor:

Jessa Hospital

Conditions:

Analgesia

Surgery

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of this study is to assess and compare the efficacy of a serratus anterior plane (SAP) block and our current pain protocol (Patient Controlled Intravenous Analgesia with opioids) in the preven...

Detailed Description

During the last two decades, cardiac surgical techniques changed dramatically. Evidence for good short and long-term outcome after endovascular and minimally invasive procedures is rising. The goal of...

Eligibility Criteria

Inclusion

  • Scheduled for elective aortic valve replacement surgery via right anterolateral thoracotomy
  • Adult patients (minimally 18 years old)
  • EuroScore ii \< 3%
  • Bodyweight \> 50 kg

Exclusion

  • Refusal to participate
  • Inability to communicate due to language or neurologic barriers
  • Inability to control and self-administer opioids with PCIA or to comprehend the NRS pain score due to confusion or learning difficulties
  • Chronic use of opioids
  • Chronic use of analgesic antidepressants and/or antiepileptics
  • History of major trauma or surgery to right chest wall
  • History of chronic pain at right chest wall
  • Allergy to opioids and/or local anesthetics
  • Allergy to acetaminophen
  • Morbid obesity (BMI \> 35)
  • Pregnancy
  • Peroperative events compromising early postoperative recovery (aortic dissection, systolic anterior motion of the mitral valve, cardiac tamponade, ..)

Key Trial Info

Start Date :

December 3 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 4 2022

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04699422

Start Date

December 3 2020

End Date

July 4 2022

Last Update

December 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr Bjorn Stessel

Hasselt, Belgium, 3500